Claraphi Advisory Network’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Claraphi Advisory Network's BMY Position: Q3 2022 in Review
Claraphi Advisory Network sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 33,702 shares — an estimated $2.6M sold.
Claraphi Advisory Network first reported a position in BMY in Q1 2020 and held it in 3 quarters. The position peaked at $2.6M in Q2 2022. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Claraphi Advisory Network reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
- Claraphi Advisory Network sold 33,702 Bristol-Myers Squibb shares in Q3 2022, an estimated $2.6M.
- Claraphi Advisory Network first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 3 quarters.
- Claraphi Advisory Network's Bristol-Myers Squibb position peaked at $2.6M in Q2 2022.
- 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Claraphi Advisory Network's 13F filing for Q3 2022, filed 15 Nov 2022.